Apropos generic Copaxone - The Indian company Natco has already launched the first generic Copaxone on May 07. As far as I know, they didn't challenge Teva's patents in court and sold their version only in India (There are about 50,000 MS patients in there and Natco's generic drug was priced at 40% discount). The reason I use past tense is because I no longer see the drug called Glatimer in their product list.
Market Data 
Markets 
AI
